Abstract:BackgroundLentiviral vectors (LVs) have enhancer activity and/or transcriptional read-through (EATRT) properties that can lead to the activation of adjacent genes. Consequently, patients may be at increased risk for adverse effects if such vectors are used clinically. MethodsIn the present study, we assessed the abilities of different pro-LV-like constructs with respect to decreasing its EATRT, including the pro-LV vector bearing a chimeric LTR of the human foamy virus R-U5 region replaced by that of an LV (HF). ResultsBy analyzing the EATRT of pro-LV constructs transfected in 293T cells, we observed that the inclusion of the first 400bp of the chicken -globin locus HS4 insulator core sequence oriented in the reverse direction (C-) combined with two copies of the simian virus 40 upstream-sequence element (U) at the U3 of LTR region of pro-LV tended to shield the adjacent genomic sequences, such that the EATRT rate was lower than when either of the C- or U was included in the pro-LV. Moreover, upon transduction, the pro-HF appears to reduce the EATRT rate in the chromosomes of 293T (by 80%) and human peripheral blood mononuclear cells (PBMCs) (by 75%) compared to when pro-LV C-U was included (with a 60% and 89% reduction in 293T and PBMCs, respectively). The HF construct had a significant reduction of viral biological titer compared tiowhen the pro-LV C-U was used in 293T cells. ConclusionsThe results of the present study provide an important basis for the clinical applicability of LVs in gene and cell therapy.

Improved Biosafety of a Lentiviral Vector by Reducing Cellular Gene Activation